Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5A | P35218 | 2/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | NT5E | P21589 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA6 | P23280 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29044711 | 0.95 | CA5A (0.42) | CA5ACA5BTSHRCA2CA1 | |
| Water SCHEMBL6822518 | 0.95 | CA5A (0.42) | CA5ACA5BTSHRCA2CA1 | |
| Lithium SCHEMBL30522213 | 0.95 | CA5A (0.42) | CA5ACA5BTSHRCA2CA1 | |
| SCHEMBL11969893 | 0.95 | CA5A (0.42) | CA5ACA5BTSHRCA2CA1 | |
| SCHEMBL10511370 | 0.76 | CA5A (0.33) | CA5ACA5B | |
| SCHEMBL868046 | 0.76 | KDM4E (0.33) | CA5ACA5BCA2 | |
| SCHEMBL9127553 | 0.70 | — | — | |
| SCHEMBL26112598 | 0.70 | CA5A (0.46) | CA5ACA5BTSHRCA2CA1 | |
| SCHEMBL3468946 | 0.67 | — | — | |
| Sulfuric Acid SCHEMBL8532128 | 0.65 | CA5A (1.00) | CA5ACA5BTSHRCA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 251 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116535335-B | Preparation method of high-purity methane trisulfonic acid trilithium | 浙江蓝天环保高科技股份有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-118878432-A | Method for preparing N- [1- (S) -ethoxycarbonyl-3-phenylpropyl ] -L-alanine by continuous flow method | 浙江昌明药业有限公司 | 2024-11-01 | — | — | CN | claimed |
| CN-116535335-A | Preparation method of high-purity methane trisulfonic acid trilithium | 浙江蓝天环保高科技股份有限公司 | 2023-08-04 | — | — | CN | claimed |
| CN-111910222-B | Electrolytic copper foil additive with brightening and leveling functions and application thereof | 九江德福科技股份有限公司 | 2022-08-23 | — | — | CN | claimed |
| CN-113214463-B | Preparation method of polyether ester random copolymer based on polyethylene glycol furanoate | 浙江恒逸石化研究院有限公司 | 2022-05-24 | — | — | CN | claimed |
| CN-113214463-A | Preparation method of polyether ester random copolymer based on polyethylene glycol furanoate | 浙江恒澜科技有限公司 | 2021-08-06 | — | — | CN | claimed |
| CN-113166090-A | Chroman-6-ols having extended lipophilic side chains in position 2, their manufacture and use | 帝斯曼知识产权资产管理有限公司 | 2021-07-23 | — | — | CN | claimed |
| US-20210130314-A1 | NOVEL USE OF SUBSTITUTED CHROMAN-6-OLS WITH EXTENDED LIPOPHILIC SIDE CHAINS | DSM IP ASSETS B.V. (NL) | 2021-05-06 | — | — | US | claimed |
| EP-3774757-A1 | CHROMAN-6-OLS WITH AN EXTENDED LIPOPHILIC SIDE CHAIN IN POSITION 2, THEIR MANUFACTURE AND USE | DSM IP Assets B.V. (NL) | 2021-02-17 | — | — | EP | claimed |
| EP-3774758-A2 | NOVEL USE OF SUBSTITUTED CHROMAN-6-OLS WITH EXTENDED LIPOPHILIC SIDE CHAINS | DSM IP Assets B.V. (NL) | 2021-02-17 | — | — | EP | claimed |
| US-20070123720-A1 | Process for the preparation of 2,3,5-trimethylhydroquinone diacylates | DSM IP ASSETS B.V. (NL) | 2007-05-31 | — | — | US | claimed |
| CN-1874988-A | Method for preparing 2,3, 5-trimethylhydroquinone diacrylate | DSM IP ASSETS BV (NL) | 2006-12-06 | — | — | CN | claimed |
| EP-1680392-A1 | PROCESS FOR THE PREPARATION OF 2,3,5-TRIMETHYLHYDROQUINONE DIACYLATES | DSM IP Assets B.V. (NL) | 2006-07-19 | — | — | EP | claimed |
| WO-2005044775-A1 | PROCESS FOR THE PREPARATION OF 2,3,5-TRIMETHYLHYDROQUINONE DIACYLATES | DSM IP ASSETS B.V. (NL) | 2005-05-19 | — | — | WO | claimed |
| JP-2738967-B2 | — | — | 1998-04-08 | — | — | JP | claimed |
| EP-0403528-B1 | PROCESS FOR THE PREPARATION OF ALKYL 3-ALKOXYPROPIONATES | EASTMAN KODAK COMPANY (US) | 1993-02-10 | — | — | EP | claimed |
| EP-0403528-A1 | PROCESS FOR THE PREPARATION OF ALKYL 3-ALKOXYPROPIONATES. | EASTMAN KODAK CO (US) | 1990-12-27 | — | — | EP | claimed |
| WO-1989008636-A1 | PROCESS FOR THE PREPARATION OF ALKYL 3-ALKOXYPROPIONATES | EASTMAN KODAK COMPANY (US) | 1989-09-21 | — | — | WO | claimed |
| US-4827021-A | REACTING A DIALKOXYMETHANE WITH A KETENE WITH A METHANEDI-OR TRISULFONIC ACID CATALYST | EASTMAN KODAK COMPANY (US) | 1989-05-02 | — | — | US | claimed |
| US-3966752-A | Resolution of D,L-protected-penicillamine | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1976-06-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210130314-A1 | NOVEL USE OF SUBSTITUTED CHROMAN-6-OLS WITH EXTENDED LIPOPHILIC SIDE CHAINS | C1S, FFAR3, FFAR1 | CA5A 4030/4885CA5B 4649/4885TSHR 667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.